PTH and hypercalcemia disease: The innate propensity of PTH to activate sustained signaling from endosomes compared to the short-lived signals from the plasma membrane by PTHrP, have been manipulated to design long-acting PTH, which triggers substantially longer cAMP responses and prolonged hypercalcemia [219].